antiplatelet and anticoagulant therapies

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/11

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

12 Terms

1
New cards

side effects of aspirin

GI bleeding, hypersensivity and bronchospasms

2
New cards

side effects of P2Y12 antagonists

dyspepsia, diarrhoea and rashes

3
New cards

dipyridamole side effect

GI disturbances, headaches, dizziness angina pectoris, rashes and myalglia (no bleeding)

4
New cards

purpura

purple bruises caused by bleeding underneath the skin

5
New cards

thrombocytopenic

number of platelets in the blood is lower than normal

6
New cards

thrombotic

formation of a blood clot inside a blood vessel

7
New cards

2 types of thrombotic thrombocytopenic purpura

inherited and aquired

8
New cards

what is inherited TTP

Mutations in the ADAMTS13 gene or immunodeficiency in the ADAMTS13 enzyme that breaks down the VWF

(rare, affecting mainly children and infants).

9
New cards

What is acquired TTP (more common)

Drug-induced (antiplatelet thienopyridines TICLOPIDINE, CLOPIDOGREL, PRASUGREL; chemotherapy; quinine)

Diseases and conditions (pregnancy; viral, infections, HIV; hepatitis, combined contraceptives)

10
New cards

Dipyridamole MOA

Inhibits PDE so ↑ cAMP/ cGMP

inhibits platelet activation

prolongs cAMP and cGMP mediated vasodilation in sm muscle cells

Blocks adenosine uptake into platelets and EC so raising extracellular adenosine concentration

-Adenosine induces vasodilation

(via A2AR increasing cAMP and cGMP)

11
New cards

6,7,8 drug list adverse effects

thrombocytopenia

12
New cards

6,7,8 MOA

Resting GIIb/IIIa R on platelets are ‘ligand-unreceptive’

Activated to ‘ligand-receptive’ conformation by platelet agonists

(ADP/ thrombin/ TxA2 / collagen)

Fibrinogen creates cross-linked bridges between GIIb/IIIa Rs to induce

platelet aggregation

Hence blocking the receptors prevents aggregation